Cambridge Investment Research Advisors’s AllianzIM U.S. Equity Buffer10 Aug ETF AUGT Stock Holding History
Bought
Maintained
Sold
Other funds holding AUGT
OMC
KAS
HI
PA
Cambridge Investment Research Advisors's AUGT Position: Q2 2026 in Review
Cambridge Investment Research Advisors reduced its AllianzIM U.S. Equity Buffer10 Aug ETF (AUGT) stake by 0.36% in Q2 2026, selling an estimated $1.08K and leaving 8,124 shares worth $309K. The position accounts for ﹤0.01% of the portfolio, ranked #3418.
Cambridge Investment Research Advisors first reported a position in AUGT in Q4 2023 and has held it in 7 quarters since. The position peaked at $334K in Q1 2024. 28 funds tracked by Wall St. Rank hold AUGT as of Q2 2026.
- Cambridge Investment Research Advisors held 8,124 shares of AllianzIM U.S. Equity Buffer10 Aug ETF worth $309K as of Q2 2026.
- Cambridge Investment Research Advisors sold 29 AllianzIM U.S. Equity Buffer10 Aug ETF shares in Q2 2026, an estimated $1.08K.
- AllianzIM U.S. Equity Buffer10 Aug ETF made up ﹤0.01% of Cambridge Investment Research Advisors's portfolio in Q2 2026, its #3418 holding.
- Cambridge Investment Research Advisors first reported a position in AllianzIM U.S. Equity Buffer10 Aug ETF in Q4 2023 and has held it in 7 quarters since.
- Cambridge Investment Research Advisors's AllianzIM U.S. Equity Buffer10 Aug ETF position peaked at $334K in Q1 2024.
- 28 funds tracked by Wall St. Rank held AllianzIM U.S. Equity Buffer10 Aug ETF as of Q2 2026.
Based on Cambridge Investment Research Advisors's 13F filing for Q2 2026, filed 27 Jul 2026.